Divisas / KURA
KURA: Kura Oncology Inc
6.30
USD
0.14
(2.17%)
El tipo de cambio de KURA de hoy ha cambiado un -2.17%. En este caso, el precio mínimo en el mercado ha alcanzado 6.21, mientras que el máximo ha alcanzado 6.55.
Siga la dinámica de la pareja de divisas Kura Oncology Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KURA News
- Seeking Alpha Kura: Ziftomenib Shift To Newly Diagnosed Mutant AML Patients Bodes Well (NASDAQ:KURA)
- Investing Kura Oncology and Kyowa Kirin enter agreement to co-promote leukemia drug in US
- Investing Cantor Fitzgerald reiterates overweight rating on Kura Oncology stock
- Investing Kura Oncology stock maintains Overweight rating on AML treatment progress
- Investing H.C. Wainwright reiterates buy rating on Kura Oncology stock at $40
- Investing H.C. Wainwright reiterates buy rating on Kura Oncology stock at $40
- Investing Citizens JMP reiterates Kura Oncology stock rating on positive trial data
- Investing Kura Oncology at Goldman Sachs Conference: Strategic Insights on ZIFTOMENIB
- Investing Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Investing Kura Oncology at Jefferies Conference: Strategic Advancements in AML
- Investing **citizens jmp reiterates market outperform rating on kura oncology stock**
- Investing Leerink Partners reiterates outperform rating for Kura Oncology stock
- Investing Cantor Fitzgerald reiterates overweight rating for Kura Oncology stock
- Investing Kura Oncology at ASCO: Strategic Moves in AML Treatment
- Investing Kura Oncology reports positive trial results for AML treatment
- Investing H.C. WAINWRIGHT REITERATES BUY RATING ON KURA ONCOLOGY STOCK
- Investing Citizens JMP highlights key ASCO presentations
- Investing Kura Oncology at TD Cowen Summit: Strategic Innovations in Menin Inhibitors
- Investing Cantor Fitzgerald maintains Overweight on Kura Oncology stock
- Investing Kura Oncology to Participate in Three Upcoming Investor Conferences
- Seeking Alpha Syndax Pharmaceuticals: Down But Not Out (NASDAQ:SNDX)
- Benzinga Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - American Axle & Mfg Hldgs (NYSE:AXL), Alumis (NASDAQ:ALMS)
- Seeking Alpha Kura Oncology: Market Sees A Tough Road Ahead, But There's An Opportunity
- Seeking Alpha Kura Oncology, Inc. (KURA) Q4 2024 Earnings Call Transcript
Rango diario
6.21
6.55
Rango anual
5.41
21.57
- Cierres anteriores
- 6.37
- Open
- 6.44
- Bid
- 6.30
- Ask
- 6.60
- Low
- 6.21
- High
- 6.55
- Volumen
- 2.574 K
- Cambio diario
- -2.17%
- Cambio mensual
- 9.76%
- Cambio a 6 meses
- -18.29%
- Cambio anual
- -69.40%
31 julio, jueves
11:30
USD
- Act.
- Pronós.
- Prev.
- 47.999 K
11:30
USD
- Act.
- Pronós.
- -68.3%
- Prev.
- -1.6%
12:30
USD
- Act.
- Pronós.
- 0.4%
- Prev.
- 0.2%
12:30
USD
- Act.
- Pronós.
- 2.6%
- Prev.
- 2.7%
12:30
USD
- Act.
- Pronós.
- 0.2%
- Prev.
- 0.1%
12:30
USD
- Act.
- Pronós.
- 2.3%
- Prev.
- 2.3%
12:30
USD
- Act.
- Pronós.
- 0.2%
- Prev.
- -0.1%
12:30
USD
- Act.
- Pronós.
- 0.7%
- Prev.
- -0.4%
12:30
USD
- Act.
- Pronós.
- 0.0%
- Prev.
- -0.3%
12:30
USD
- Act.
- Pronós.
- 0.9%
- Prev.
- 0.9%
12:30
USD
- Act.
- Pronós.
- 1.0%
- Prev.
- 1.2%
12:30
USD
- Act.
- Pronós.
- 0.7%
- Prev.
- 0.8%
12:30
USD
- Act.
- Pronós.
- 224 K
- Prev.
- 217 K
12:30
USD
- Act.
- Pronós.
- 1.966 M
- Prev.
- 1.955 M
12:30
USD
- Act.
- Pronós.
- 222.299 K
- Prev.
- 224.500 K
13:45
USD
- Act.
- Pronós.
- 42.4
- Prev.
- 40.4
14:00
USD
- Act.
- Pronós.
- 2.3%
- Prev.
- 2.0%
14:30
USD
- Act.
- Pronós.
- 2 B
- Prev.
- 23 B
15:30
USD
- Act.
- Pronós.
- Prev.
- 4.245%
15:30
USD
- Act.
- Pronós.
- Prev.
- 4.265%